NAGE Competitors & Alternatives
Compare Niagen Bioscience, Inc. with similar stocks in the same industry
Biotechnology
NAGE
Main Stock$3.65
Tradestie Score
54
Market Cap
$629.25M
P/E Ratio
18.1
Revenue Growth
0.0%
Analyst Upside
+245.2%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ALT
Altimmune, Inc. Common Stock
|
$2.85
|
$341.56M | - | 60 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.21
|
$332.96M | - | 48 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$13.72
|
$308.74M | - | 56 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$8.77
|
$304.12M | - | 61 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$23.36
|
$297.23M | - | 52 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$27.89
|
$293.03M | - | 53 | Compare |
|
OMER
Omeros Corporation
|
$12.25
|
$281.75M | 11.6 | 51 | Compare |
|
DBVT
DBV Technologies S.A.
|
$19.65
|
$275.54M | - | 53 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$2.00
|
$275.13M | - | 41 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$14.63
|
$269.08M | - | 49 | Compare |
More NAGE Analysis
Data updated: May 15, 2026 | Industry: Biotechnology (SIC 2833)
232 stocks in this industry